Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Sweden
/
Pharmaceuticals & Biotech
Create a narrative
BioGaia Community
OM:BIOG B Community
1
Narratives
written by author
0
Comments
on narratives written by author
7
Fair Values set
on narratives written by author
Create a narrative
BioGaia
Popular
Undervalued
Overvalued
Community Investing Ideas
BioGaia
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Launch Of Gastrus PURE ACTION And Prodentis Lozenges Will Expand Global Market Presence
Key Takeaways Strategic market expansion and direct sales initiatives in key countries could enhance net margins and revenue growth by capturing more customer value. Investments in R&D for new clinical studies may result in innovative products, driving future revenue and sustaining high EBIT margins through differentiation.
View narrative
SEK 150.00
FV
33.7% undervalued
intrinsic discount
9.69%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
6 days ago
author updated this narrative
Your Valuation for
BIOG B
BIOG B
BioGaia
Your Fair Value
SEK
Current Price
SEK 99.45
13.9% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
2b
2015
2018
2021
2024
2025
2027
2030
Revenue SEK 2.2b
Earnings SEK 550.9m
Advanced
Set Fair Value